BOSTON, July 12, 2023 /PRNewswire/ — Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr. Liu Jian as the President of Drug Discovery Division. Medicilon recognizes the importance of drug discovery as the cornerstone of new drug innovation. With expertise in modern synthetic chemistry, Medicilon excels…Read More
Medicilon Appoints Dr Liu Jian as President of Drug Discovery Division
